Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT
Condition(s):Hepatocellular Carcinoma Non-resectableLast Updated:February 20, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Hepatocellular Carcinoma Non-resectableLast Updated:February 20, 2024Completed
Condition(s):Pancreas Cancer; Lung Cancer; Liver Cancer; Mesothelioma; CAR-T Cell Therapy; Solid Tumor, AdultLast Updated:January 9, 2024Not yet recruiting
Condition(s):Solid Tumor, AdultLast Updated:January 9, 2024Not yet recruiting
Condition(s):Solid Tumor, AdultLast Updated:January 9, 2024Not yet recruiting
Condition(s):Transplant Complication; Diabetic Nephropathy; Perioperative/Postoperative ComplicationsLast Updated:October 23, 2023Completed
Condition(s):Thrombocytopenia; Hepatocellular CarcinomaLast Updated:September 14, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:September 14, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:September 14, 2023Recruiting
Condition(s):Hepatocellular Carcinoma Non-resectableLast Updated:August 14, 2023Recruiting
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:July 28, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.